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OBJECTIVES We intended to study the effect of hypercholesterolemia (HC) on myocardial perfusion and
permeability response to increased cardiac demand.
BACKGROUND Hypercholesterolemia is associated with increased incidence of cardiac events and character-
ized by impaired coronary vascular function, possibly mediated partly through increased
pro-oxidative conditions in plasma and tissue. However, it is yet unclear whether HC is also
associated with impaired myocardial perfusion and vascular permeability responses in vivo.
METHODS For 12 weeks pigs were fed a normal, HC or HC diet supplemented daily with antioxidants
(HC 1 AO, 100 IU/kg vitamin E and 1 g vitamin C). Myocardial perfusion and vascular
permeability were measured in vivo using electron beam computed tomography before and
after cardiac challenge with intravenous adenosine. Plasma and tissue oxidative status was
determined ex vivo.
RESULTS Plasma cholesterol increased in all cholesterol-fed pigs but was associated with increased
markers of oxidative stress only in HC pigs. Myocardial perfusion increased in response to
adenosine in normal and HC 1 AO (137 6 13% and 158 6 22%, respectively, p , 0.05
vs. baseline) but not in HC, whereas vascular permeability index increased only in HC pigs
(1 92 6 25%, p 5 0.002). In HC animals, tissue endogenous oxygen radical scavengers and
antioxidant vitamins were depleted and LDL oxidizability enhanced, but both were
normalized in HC 1 AO pigs. Myocardial perfusion response was directly, and permeability
inversely, associated with plasma and tissue vitamin concentrations.
CONCLUSIONS This study demonstrates that experimental HC is associated with blunted myocardial
perfusion and increased vascular permeability responses in vivo to increased cardiac demand,
which may be partly mediated by a shift in oxidative status. (J Am Coll Cardiol 2001;37:
608–15) © 2001 by the American College of Cardiology
Hypercholesterolemia (HC) is considered a major risk
factor for progression of coronary atherosclerosis and is
associated with an increase in the incidence of myocardial
ischemia and cardiac events (1,2). Hypercholesterolemia is
characterized by coronary endothelial dysfunction, the hall-
mark of which is an altered vasodilation to endothelial-
dependent vasodilators (3,4). Because many regulatory
mechanisms contribute to the determination of basal vas-
cular tone, it appears to be balanced under resting condi-
tions, and abnormalities are often apparent only in stimu-
lated situations (5) such as exercise or increased cardiac
demand. Alterations in microvascular permeability (6) have
also been postulated to be a measure of coronary endothelial
dysfunction in HC (7,8) and may indicate functional or
structural loss of coronary vascular integrity. Nevertheless,
the functional significance of these impairments in coronary
vascular function remains unclear, because it is yet to be
elucidated whether HC, as a sole risk factor, is associated
with significant abnormalities of myocardial perfusion in
vivo.
One mechanism that may underlie the abnormal coronary
vascular function in HC is an alteration in the oxidative
status (9) accompanied by increased production of several
oxidants such as peroxynitrites, as well as peroxidation
compounds and oxidative end-products such as PGF2-a
isoprostanes (9–11). Furthermore, a shift in oxidative status
with a decrease in nitric oxide (NO) and an increase in
oxygen radicals may have a deleterious effect on vascular
permeability (12–14). Thus, these mechanisms may play a
pivotal role in inducing abnormalities of both myocardial
perfusion and vascular permeability associated with HC.
Quantification of the myocardial perfusion and perme-
ability abnormalities that exist in HC in vivo may have
important implications for understanding and management
of HC as a risk factor for coronary heart disease. However,
few methods are capable of accurately and noninvasively
measuring myocardial perfusion and permeability in vivo.
Electron beam computed tomography (EBCT), a fast com-
puted tomography (CT) scanner, provides a unique tool to
accurately (15), reproducibly (16) and noninvasively study in
vivo myocardial perfusion (15,17) and microvascular perme-
ability (18–20). Electron beam computed tomography mea-
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surements of myocardial perfusion correlate well with con-
current radioactive microspheres measurements (15) and
show little short-term variability (16). This method uses
fast-acquired cross-sectional tomographic images during a
single intravenous bolus injection of contrast media and
permits repeated study of myocardial perfusion in animals
(17) and humans (15) within the same myocardial region,
thus minimizing effects of spatial heterogeneity or imaging
artifacts on the calculated perfusion or microvascular per-
meability. Hence, EBCT provides a unique tool to nonin-
vasively calculate myocardial vascular function in different
pathophysiological states in vivo.
The present study was designed to test the hypothesis
that experimental HC is associated with abnormal myocar-
dial perfusion and microvascular permeability response to
increased myocardial demand. Furthermore, this study
demonstrates that these abnormalities are due partly to a
shift in oxidative status.
METHODS
All procedures were designed in accordance with the Na-
tional Institutes of Health Guidelines and were reviewed
and approved by the Institutional Animal Care and Use
Committee. Domestic crossbred pigs (23 to 35 kg) were
divided in three groups (subsequently treated for 12 weeks):
group 1 (n 5 8) received a normal diet. Pigs in groups 2
(HC, n 5 8) and 3 (n 5 6) were placed on an atherogenic
diet of 2% cholesterol and 15% lard by weight (TD 93296,
Harlan Teklad, Madison, Wisconsin). In addition, animals
from group 3 (HC 1 AO) received daily supplementation
of an antioxidant combination consisting of vitamin E
(100 IU/kg) and vitamin C (1,000 mg). These doses of
vitamins are higher than those used clinically but are
commonly used experimentally to explore their effects and
participation in disease mechanisms (21–24)
In vivo studies, plasma lipid profiles (Roche, Nutley, New
Jersey), total isoprostanes (25), low density lipoprotein
(LDL) oxidizability, tissue oxygen radical scavengers and
circulating levels of vitamin E and C were determined after
12 weeks of diet in all three groups.
Assessment of myocardial perfusion. Animals were anes-
thetized with a mixture of ketamine and xylazine, intubated
and mechanically ventilated with room air. Anesthesia was
maintained with a constant infusion of ketamine (17.5
mg/kg/h) and xylazine (2.3 mg/kg/h) in saline. The carotid
artery and jugular vein were cannulated, and under fluoro-
scopic guidance an 8F guide catheter was positioned in the
descending aorta for on-line measurement of arterial pres-
sure. A 5-F pigtail catheter was inserted in the right atrium
for subsequent injection of contrast media.
Animals were then placed supine in the EBCT (Imatron
C-150, Imatron Inc., South San Francisco, California)
gantry. Using localization scans, images containing the
mid-left ventricle (mid-LV) were identified in the neutral
axis of the heart. After allowing 30 min of stabilization and
saline infusion (5 ml/min), a baseline perfusion study was
performed. Two tomographic levels were selected and 40
consecutive end-diastolic scans were obtained (17) at inter-
vals of one to three heartbeats after a bolus injection of
nonionic contrast iopamidol (Isovue-370, Squibb Diagnos-
tics, Princeton, New Jersey, 0.3 cc/kg over 2 s). Ten minutes
later an IV infusion of adenosine (approximately 400 mg/
kg/min) was initiated (simulating a cardiac stress test). After
stabilization of blood pressure, hemodynamic measurements
were obtained and the perfusion study was repeated. After
completion of the studies, animals were euthanized by
intravenous administration of 30 mg/kg pentobarbital so-
dium (Sleepaway, Fort Dodge Laboratories, Iowa). Images
were then transferred and stored on a Sun workstation
EBCT data analysis. Regions of interest were traced in the
anterior wall and chamber of the LV and time-density
curves (17,26) were obtained (Fig. 1A). To define the
transmural distribution of blood flow, the myocardial region
of interest was further subdivided into two equidistant
subepicardial and subendocardial zones. Time-density
curves were then generated and analyzed with commercially
available computer software (KaleidaGraph, Synergy Soft-
ware, Reading, Pennsylvania) containing custom-designed
algorithms, which allow modeling of intravascular and
extravascular transit of contrast media (17) (Fig. 1B).
Calculation of myocardial perfusion used the intravascu-
lar curve, which portrays transit of contrast media within the
intramyocardial vasculature. Intramyocardial vascular blood
volume (BV) (ml/cc tissue) (17,27–29) and mean transit
time (MTT) (s) (30) were calculated as previously described.
Myocardial perfusion (ml/g/min) was calculated (15,17)
as 60 3 (BV/MTT)/[1.05 3 (12BV)]. Perfusion of the
subendocardial and subepicardial regions was similarly ob-
tained and their ratio (endocardial/epicardial) was calcu-
lated.
For calculation of myocardial vascular permeability index,
the rate of vascular leakage was estimated from the extravas-
cular accumulation of contrast media, as previously de-
scribed in the heart (18,19) and the kidney (31). Contrast
extraction rate (analogous to permeability-surface area
Abbreviations and Acronyms
ANOVA 5 analysis of variance
AU 5 arbitrary units
BV 5 blood volume
CT 5 computed tomography
EBCT 5 electron beam computed tomography
HC 5 hypercholesterolemia
HC 1 AO 5 HC plus long-term vitamin supplementation
LDL 5 low density lipoprotein
LV 5 left ventricle
MTT 5 mean transit time
NO 5 nitric oxide
REM 5 relative electrophoretic mobility
SOD 5 superoxide dismutase
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product) was then calculated from the curve depicting the
extravascular permeation of contrast media (17) as:
60 3 1.05 3 ~slope of extravascular curve 3 MTT!/
area under input curve
where slope is the maximal slope of the ascending arm of the
extravascular curve, MTT estimates the duration of leakage
and 1.05 g/cc is the specific density of the myocardium.
Blood volume was subsequently used as a surrogate for
vascular surface area (19) and permeability index (arbitrary
units; AU) was calculated as extraction rate/BV (19).
LDL isolation and oxidation. Plasma was obtained from
each experimental group and LDL was rapidly isolated by
two consecutive steps of discontinuous density ultracentrif-
ugation in a KBr gradient as previously described (32). A
Sephacryl S-300 column was used to desalt and remove
low-molecular-weight components. Fresh LDL prepara-
tions were immediately used to minimize spontaneous
peroxidation (32). Protein content was determined by the
Lowry assay (33). Low density lipoprotein (300 mg/ml) was
incubated for 12 h at 37° C with 1 mm copper sulfate and lag
time was measured spectrophotometrically as previously
detailed (32,34). Malondialdehyde content was assayed by
thiobarbituric acid and relative electrophoretic mobility
(REM) of lipoproteins on agarose gel (0.8%) was assessed
(32,34). Vitamin E and C concentration in plasma and
tissue was determined by high-performance liquid chroma-
tography (35).
Determinations of tissue antioxidant enzymes. Tissue
concentrations of oxygen-radical scavengers were deter-
mined in left coronary artery segments and in the myocar-
dium. Homogenates in potassium phosphate buffer, pH 7.4,
containing 10 mol/l deferoxamine, 0.03% butylated hy-
droxytoluene and 2% ethanol, equilibrated with nitrogen (to
reduce auto-oxidation) were centrifuged at 1,000 g for
15 min at 4 °C to remove nuclei and tissue debris. The
supernatant was centrifuged again at 30,000 g for 35 min at
4°C. Glutathione peroxidase, catalase, copper zinc-
superoxide dismutase (SOD) and manganese-SOD tissue
activities were determined spectrophotometrically as previ-
ously described (36). All enzyme activities were normalized
for protein content (33).
Statistical Analysis
Data are expressed as mean 6 SEM. Comparisons between
the groups were performed using analysis of variance
(ANOVA) followed by the Bonferroni corrected t test or
unpaired Student t test, as applicable. Comparisons within
each group were done using paired Student t test. Regres-
sions were calculated by the least-squares method. Statistical
significance was accepted for p # 0.05.
RESULTS
Systemic hemodynamics. Basal mean arterial pressure and
heart rate were similar among the three experimental groups
(Table 1). In response to IV adenosine, mean arterial
pressure decreased significantly and similarly in all groups
(Table 1).
Serum cholesterol and 8-iso-PGF2 alpha isoprostane
levels. Total and LDL cholesterol levels were significantly
increased in both groups of HC pigs compared with normal
pigs (Table 1). There was no difference in cholesterol levels
between HC and HC 1 AO pigs (Table 1), indicating that
antioxidant supplementation had no effect on cholesterol levels.
The increase in serum cholesterol was associated with a
significant increase in plasma isoprostanes in HC animals
compared with normal pigs (p 5 0.005, Table 1), repre-
senting increased oxidative stress (37). The increase in
plasma isoprostanes observed in HC was attenuated, al-
though not completely normalized, in HC animals receiving
long-term vitamin supplementation, because their levels
were similar to those in both groups.
Figure 1. (A) Tomographic cross-sectional image of the heart at the level
of the mid-LV, showing a traced anterior wall region-of-interest, and
contrast media in the LV cavity. (B) Time-density curves consequent to
transit of contrast media through the anterior cardiac wall region of interest
(closed circles), depicting the modeling of intra- and extra-vascular curves
(triangle and square symbols, respectively). LV 5 left ventricle.
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Myocardial perfusion. Anterior wall myocardial perfu-
sion was similar under basal conditions among the three
experimental groups (normal: 0.95 6 0.1, HC: 0.89 6
0.1, and HC 1 AO: 0.93 6 0.1 ml/min/g myocardial
tissue, ANOVA, p 5 0.48). Adenosine infusion led to a
significant increase in myocardial perfusion in normal
animals (to 1.25 6 0.2 ml/min/g tissue, p 5 0.02, Fig. 2,
top panel) but not in HC pigs (to 0.93 6 0.1 ml/min/g
tissue, p 5 0.28). On the other hand, in HC 1 AO pigs,
the response of myocardial perfusion to adenosine was
Figure 2. Top panel: Relative change (percent compared with baseline) of anterior wall myocardial perfusion in response to IV adenosine in normal pigs
(n 5 8), hypercholesterolemic pigs (HC, n 5 8), and HC pigs that received dietary antioxidant supplementation (HC 1 AO, n 5 6). Bottom panel:
Relative change (percent compared with baseline) of anterior wall microvascular permeability index in response to IV adenosine in normal, HC and HC 1
AO pigs. *p , 0.05 compared with normal and HC 1 AO pigs. HC 5 hypercholesterolemia; HC 1 AO 5 HC plus long-term vitamin supplementation.
Table 1. Systemic Hemodynamics (at Baseline and in Response to IV Adenosine), Lipid Profiles (Cholesterol Fractions and
Triglycerides, mg/dl), and Total PGF2}-Isoprostanes (pg/ml) in Normal, HC and HC1Antioxidants Pigs
Normal HC HC1AO
Systemic hemodynamics Baseline MAP 117 6 5 115 6 4 111 6 5
HR 79 6 4 71 6 3 84 6 7
Adenosine MAP 100 6 5* 105 6 9* 99 6 10*
HR 83 6 3 76 6 8 100 6 16
Cholesterol Total 90 6 8 439 6 38* 467 6 56*
HDL 34 6 9 91 6 10* 91 6 16*
TG 41 6 19 42 6 7 35 6 7
LDL 41 6 19 265 6 35* 362 6 62*
Isoprostanes 102 6 10 166 6 20* 137 6 15
*p # 0.05 compared to normal.
HC 5 hypercholesterolemia; HC1AO 5 HC plus antioxidant vitamins; HDL 5 high density lipoproteins; HR 5 heart rate (bpm); MAP 5 mean arterial pressure (mm
Hg); LDL 5 low density lipoprotein; TG 5 triglycerides.
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normalized (to 1.67 6 0.2 ml/min/g tissue, p 5 0.03,
Fig. 2, top panel).
The basal ratio of endocardial/epicardial perfusion was
similar in the normal, HC and HC 1 AO groups (1.26 6
0.27, 1.33 6 0.13, and 1.21 6 0.14, respectively, p 5
0.914). Intravenous infusion of adenosine was not associated
with significant intramyocardial redistribution of perfusion
in any group.
Myocardial microvascular permeability. The 12-week
diet led to similar basal myocardial permeability index in
normal, HC and HC 1 AO pigs (1.61 6 0.2, 1.15 6 0.2,
and 1.30 6 0.2 AU, respectively, p 5 0.34). In response to
adenosine, there was no change in permeability index in
normal pigs (to 1.76 6 0.3 AU, p 5 0.56, Fig. 2, bottom
panel). However, in HC pigs adenosine infusion led to a
significant increase in the permeability index (to 2.08 6 0.3
AU, p 5 0.002, Fig. 2). Similar to normal pigs, in HC 1
AO pigs the permeability index response to adenosine was
preserved (1.02 6 0.46 AU, p 5 0.21, Fig. 2, bottom
panel).
Status of antioxidant defenses and LDL oxidizability.
Plasma vitamins E and C were significantly decreased in
HC pigs compared with normal (p 5 0.02, Table 2),
although tissue levels were similar. In contrast, tissue
scavenging enzyme activities were all significantly lower in
HC pigs compared with both normal and HC 1 AO pigs
(Table 2). The susceptibility of LDL for oxidation was also
markedly increased in the HC pigs, as evidenced by an
increase in LDL-malondialdehyde and LDL-REM and a
shortening of LDL-lag time (Table 2).
Twelve weeks of daily supplementation resulted in a
significant increase in plasma levels of both vitamins E and
Figure 3. Top panel: Correlation between the change in myocardial perfusion in response to adenosine in hypercholesterolemic (HC) pigs and
vitamin-treated HC pigs with tissue (right) and systemic (left)) levels of vitamins E (open circles) and C (closed circles). Bottom panel: Correlation
between the change in microvascular permeability in response to adenosine in HC and vitamin-treated HC pigs with tissue (right) and systemic (left) levels
of vitamins E and C.
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C in the HC 1 AO pigs compared with both normal and
HC pigs (both p , 0.00001, Table 2). More importantly, in
the HC 1 AO pigs antioxidant supplementation com-
pletely normalized tissue levels of scavenging enzymes, all of
which were also significantly higher than in the HC pigs,
indicating restoration of endogenous antioxidant and scav-
enging defenses. Tissue levels of vitamin E were signifi-
cantly higher than normal (p 5 0.0002), whereas LDL-
REM was significantly lower (p 5 0.015) and LDL-lag
time significantly longer (p 5 0.001) than in normal pigs as
well as in HC pigs (p , 0.00001 for all measurements).
The change in myocardial perfusion in response to
adenosine in HC and HC 1 AO pigs correlated directly
with plasma concentrations of vitamins E and C (r 5 0.68;
p 5 0.01 and r 5 0.48; p 5 0.03, respectively, Fig. 3, top
left panel), LDL lag time (r 5 0.68, p 5 0.0006), and tissue
levels of copper zinc-SOD (r 5 065, p 5 0.04). Moreover,
the change tended to correlate with tissue levels of vitamins
E and C (r 5 0.53, p 5 0.09 and r 5 0.53, p 5 0.09,
respectively, Fig. 3, top right panel). Changes in microvas-
cular permeability correlated inversely with plasma concen-
trations of vitamins E and C (r 5 20.58; p 5 0.007 and r 5
20.59; p 5 0.006, respectively, Fig. 3, bottom left panel), as
well as with tissue levels of vitamin E (Fig. 3, bottom right
panel) and manganese-SOD (r 5 20.68; p 5 0.02 each). In
normal pigs there were no significant correlations; myocar-
dial perfusion responses to adenosine did not correlate
significantly in any group with either total or LDL choles-
terol or with 8-iso-PGF2 alpha isoprostanes.
DISCUSSION
This study demonstrates that experimental HC, a pro-
oxidant state (9–11), is associated with an attenuated
myocardial perfusion and increased microvascular perme-
ability in response to increased cardiac demand. Moreover,
these abnormalities may be partly mediated by an increase in
oxidative stress.
Hypercholesterolemia and myocardial perfusion. Hyper-
cholesterolemia is a major risk factor for development of
coronary atherosclerosis, and several clinical studies have
shown that its presence is associated with an increased inci-
dence of cardiac events (1,2). Early HC is characterized by
coronary endothelial dysfunction. Because the increase in
coronary flow and myocardial perfusion is in part mediated by
the endothelium, endothelial dysfunction may conceivably
contribute to myocardial ischemia. Indeed, studies from our
laboratory and others have demonstrated that in humans
coronary endothelial dysfunction per se may lead to myocardial
perfusion defects (38,39) and increased prevalence of myocar-
dial events (40). Hence, it was postulated that early HC might
impose a deleterious effect on myocardial perfusion response to
increased cardiac demand. The current study supports this
hypothesis in demonstrating that experimental HC is charac-
terized by an attenuated myocardial perfusion response to
increased cardiac demand. Nevertheless, in addition to in-
creased cardiac demand, myocardial perfusion response in this
study was likely also elicited by both endothelium-dependent
and independent mechanisms triggered by modest doses of IV
adenosine. The transmural distribution of perfusion was unaf-
fected by HC, suggesting homogeneity of this impairment
throughout the anterior cardiac wall.
Hypercholesterolemia and oxidative stress. One of the
mechanisms that may underlie endothelial dysfunction is an
increase in pro-oxidative conditions (41). Hypercholesterol-
emia is associated with increased production of oxygen radicals
and increased oxidation of LDL cholesterol (9–11). Oxidation
of LDL is implicated in the pathogenesis of early atherogenesis
in human fetuses (42) and children (43). Oxidized LDL may
directly induce endothelial dysfunction that can be prevented
by vascular incorporation of vitamin E (44). Accordingly, in
the present study LDL oxidizability was increased in HC pigs
and significantly reduced by the antioxidant vitamins E and C.
Moreover, production of oxygen radicals may further decrease
the bioavailability of NO, thus leading to inadequate
Table 2. Free Radical Scavengers in Plasma, Coronary and Myocardial Tissue, and Susceptibility
of LDL for Oxidation in Normal, HC Pigs and HC Pigs that Received Daily Supplementation
of a Combination of the Antioxidant Vitamins E and C (HC 1 AO)
Normal HC HC 1 AO
Tissue levels
Gluthatione-peroxidase (mU/mg protein) 76.0 6 2.5 59.8 6 6.0*† 84.6 6 4.2
Catalase (mU/mg protein) 20.8 6 1.3 17.8 6 0.8*† 22.0 6 1.3
CuZn-SOD (mU/mg protein) 8.0 6 0.7 6.9 6 0.2*† 8.0 6 0.2
Mn-SOD (mU/mg protein) 2.4 6 0.1 2.0 6 0.1*† 2.4 6 0.1
Vitamin E (mg/mg protein) 0.64 6 0.03 0.59 6 0.02† 0.89 6 0.02*
Ascorbic acid (mg/mg protein) 1.17 6 0.11 1.13 6 0.02† 1.32 6 0.04
Plasma levels
Vitamin E (mmol/L) 62.2 6 4.3 51.9 6 1.7*† 170.6 6 11.5*
Ascorbic acid (mmol/L) 97.0 6 5.6 84.8 6 2.0*† 132.6 6 7.9*
LDL-MDA (nM/mg protein) 6.9 6 0.3 8.7 6 0.2*† 6.6 6 0.2
LDL-REM (mm from baseline) 11.1 6 0.3 12.6 6 0.3*† 9.9 6 0.3*
LDL-Lag time (minutes) 87.5 6 3.6 75.1 6 2.2*† 121.4 6 7.3*
*p , 0.05 compared to normal; †p , 0.05 HC vs. HC 1 AO groups. HC 5 hypercholesteromia; HC 1 AO 5 HC plus
long-term vitamin supplementation; MDA 5 malondialdehyde; REM 5 relative electrophoretic mobility; SOD 5 superoxide
dismutase.
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endothelium-dependent responses (41). This study shows that
an increase in oxidative stress may contribute to the impaired
myocardial perfusion response in HC, as evidenced by the
preservation of the myocardial perfusion response achieved
when HC pigs received long-term combination antioxidant
supplementation.
Hypercholesterolemia and microvascular permeability.
In addition to providing the myocardium with adequate
blood supply, intramyocardial circulation has other momen-
tous roles. For example, the integrity of the endothelium
serves as a barrier between the circulation and the vascular
wall and may thus be regarded as a parameter of endothelial
function. Furthermore, in pathophysiological states such as
HC, abnormalities in myocardial vascular permeability (7)
have been suggested as a parameter of endothelial dysfunc-
tion. Although our model of early atherosclerosis does not
show development of early atheromatous plaques or coro-
nary luminal obstruction (45), it is characterized by in-
creased fenestration of the coronary internal elastic lamina
(46). This study supports the notion that such changes may
have functional significance upon increased demand. It also
demonstrates for the first time that experimental HC is
associated with an increase in microvascular permeability in
response to cardiac challenge in vivo and that this impair-
ment may be mediated by an increase in oxidative status.
Vitamin E and vitamin C both are potent antioxidants,
which retard oxidative modification of LDL (47) and
endothelial dysfunction (44). Such effects may have clinical
benefits (48) that are likely to be dependent, among the rest,
on the duration, dose, timing and combination of dietary
supplementation, as recently reviewed in detail (24,49). For
example, antioxidant effects may be partly synergistic, be-
cause vitamin C contributes to regeneration of vitamin E. In
this study we investigated another important effect of
antioxidants and showed that daily dietary supplementation
of a high-dose combination of both vitamins E and C was
effective in elevating their circulating levels and tissue
concentrations and in normalizing oxidative status, partic-
ularly myocardial perfusion and permeability response to
challenge. A direct vasodilatory effect of vitamin E at the
relatively high doses utilized in this study cannot be ex-
cluded either. The preservation of endogenous scavenging
activities in the heart of the vitamin-treated group can also
improve cardiac function.
In summary, this study demonstrates for the first time
that experimental HC is associated with blunted myocardial
perfusion and increased microvascular permeability in vivo
in response to cardiac challenge. This study also indicates
that these abnormalities are associated with an increase in
oxidative stress in HC.
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